STK19 Antibodies

Santa Cruz Biotechnology provides a broad selection of STK19 monoclonal antibodies for investigating STK19 in various biological processes. STK19 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STK19, or serine/threonine kinase 19, is involved in several cellular signaling pathways and plays a crucial role in regulating cell growth and differentiation. STK19 has garnered significant attention in cancer research, as changes in STK19 expression levels can influence tumor progression and treatment response. Research focused on STK19 mechanisms continues to reveal potential therapeutic targets for various diseases. Investigating STK19 expression patterns helps researchers understand its role in both normal cellular functions and disease states. Detailed analysis of STK19 activity provides insights into cellular regulation and signal transduction pathways. STK19 research contributes to the development of targeted therapies and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of STK19's role in human health and disease.